Ojas Pharmaceuticals Private Limited
Ojas Pharmaceuticals Private Limited is a Private Indian company incorporated in 1993 and based in Telangana, India. Ojas Pharmaceuticals Private Limited operates in Pharmaceuticals & Chemicals (NIC 24230) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Explore the financials, board members, legal insights, and much more in the complete profile of OJAS PHARMACEUTICALS PRIVATE LIMITED.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Ojas Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +1d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +11d | filed |
| MGT-7 | FY2023-24 | 22 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Ojas Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 278667256 | Axis Bank Ltd(Bank) | ₹4.87 Cr | 12 Mar 2020 | Open |
| 391093089 | Axis Bank Ltd(Bank) | ₹7.39 Cr | 27 Jan 2020 | Open |
| 142585910 | Axis Bank Ltd(Bank) | ₹22.61 Cr | 12 Mar 2019 | Open |
| 780145220 | Kotak Mahindra Bank Ltd(Bank) | ₹18.43 Cr | 04 Jul 2019 | Open |
Charge IDs, lenders & amounts for Ojas Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹21.34 Cr | ₹2.75 Cr | ₹10.71 Cr | ₹31.36 Cr | 196 |
| FY2023-24 | ₹17.87 Cr | ₹1.63 Cr | ₹9.02 Cr | ₹26.16 Cr | 254 |
| FY2022-23 | ₹18.41 Cr | ₹2.33 Cr | ₹12.50 Cr | ₹23.57 Cr | 71 |
| FY2021-22 | ₹17.53 Cr | ₹1.65 Cr | ₹8.64 Cr | ₹23.74 Cr | 334 |
Audited financials & ratios for Ojas Pharmaceuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹21.34 Cr | ₹17.87 Cr | ₹18.41 Cr | ₹17.53 Cr |
| Other income | ₹49.87 L | ₹22.05 L | ₹25.45 L | ₹9.64 L |
| Total income | ₹21.83 Cr | ₹18.09 Cr | ₹18.67 Cr | ₹17.62 Cr |
| Total expenses | ₹18.32 Cr | ₹16.01 Cr | ₹15.68 Cr | ₹15.51 Cr |
| Profit before tax | ₹3.57 Cr | ₹2.12 Cr | ₹3.03 Cr | ₹2.15 Cr |
| Profit / (Loss) after tax | ₹2.75 Cr | ₹1.63 Cr | ₹2.33 Cr | ₹1.65 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹10.71 Cr | ₹9.02 Cr | ₹12.50 Cr | ₹8.64 Cr |
| Borrowings | ₹9.92 Cr | ₹6.41 Cr | ₹5.70 Cr | ₹7.66 Cr |
| Current liabilities | ₹11.91 Cr | ₹9.77 Cr | ₹3.80 Cr | ₹6.54 Cr |
| Total liabilities | ₹20.66 Cr | ₹17.14 Cr | ₹11.08 Cr | ₹15.09 Cr |
| Current assets | ₹18.31 Cr | ₹11.36 Cr | ₹13.43 Cr | ₹10.44 Cr |
| Cash & equivalents | ₹3.16 Cr | ₹2.26 Cr | ₹4.41 Cr | ₹3.04 Cr |
| Total assets | ₹31.36 Cr | ₹26.16 Cr | ₹23.57 Cr | ₹23.74 Cr |
| Employees | 196 | 254 | 71 | 334 |
Audited financials & ratios for Ojas Pharmaceuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹21.34 Cr | +22.3% | -2.6% | -1.4% |
| Profit after Tax | ₹2.75 Cr | +18.5% | +6.6% | +20.1% |
| Net Worth | ₹10.71 Cr | +8.0% | -0.4% | +7.7% |
| Employees | 196 | +6.4% | +25.7% | +16.7% |
Audited financials & ratios for Ojas Pharmaceuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹21.34 Cr | ₹2.75 Cr | +12.87% | +0.10% | +25.66% | +8.76% | 0.93 | ₹10.89 L |
| FY2023-24 | ₹17.87 Cr | ₹1.63 Cr | +9.13% | +39.46% | +18.09% | +6.24% | 0.71 | ₹7.04 L |
| FY2022-23 | ₹18.41 Cr | ₹2.33 Cr | +12.68% | +39.82% | +18.68% | +9.90% | 0.46 | ₹25.93 L |
| FY2021-22 | ₹17.53 Cr | ₹1.65 Cr | +9.44% | +14.13% | +19.14% | +6.97% | 0.89 | ₹5.25 L |
Audited financials & ratios for Ojas Pharmaceuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 2,15,64,564 | 74.62% |
| Institutional Investors | 2 | 19,82,329 | 6.86% |
| Public & Others | 42 | 53,53,358 | 18.52% |
Promoter, institutional & public holding for Ojas Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
50 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.